Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice

about

Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice

Item

http://www.wikidata.org/entity/Q58724364

description

scientific article published on 22 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Anti-tau conformational scFv M ...... au species in adult JNPL3 mice

@en

Anti-tau conformational scFv M ...... au species in adult JNPL3 mice

@nl

type

Item

label

Anti-tau conformational scFv M ...... au species in adult JNPL3 mice

@en

Anti-tau conformational scFv M ...... au species in adult JNPL3 mice

@nl

prefLabel

Anti-tau conformational scFv M ...... au species in adult JNPL3 mice

@en

Anti-tau conformational scFv M ...... au species in adult JNPL3 mice

@nl

P1476

Anti-tau conformational scFv M ...... au species in adult JNPL3 mice

@en

P2093

Francesca Vitale

http://www.w3.org/2001/XMLSchema#string

Kristen Steslow

http://www.w3.org/2001/XMLSchema#string

Luca Giliberto

http://www.w3.org/2001/XMLSchema#string

Santiago Ruiz

http://www.w3.org/2001/XMLSchema#string

P2860

Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models

Neuropathological stageing of Alzheimer-related changes

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

Stability engineering of antibody single-chain Fv fragments.

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

Immune responses to adeno-associated virus vectors.

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity

P2888

s40478-018-0585-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40478-018-0585-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Marambaud

Cristina d'Abramo

P577

2018-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106283976

http://www.w3.org/2001/XMLSchema#string

P698

30134961

http://www.w3.org/2001/XMLSchema#string

P932

6103963

http://www.w3.org/2001/XMLSchema#string